Literature DB >> 6873567

[Treatment of intractable ascites in cirrhotic patients by portal shunt].

D Franco.   

Abstract

Forty one patients with chronic liver disease and intractable ascites were treated by a portal-systemic shunt. Operative mortality was 4.8 p. 100. Ascites was definitely cleared in 97 p. 100 of the 39 survivors. Fourteen patients later developed encephalopathy which was severe in 6 (15.3 p. 100). One-year survival rate was 72 p. 100. Late deaths were mainly due to complications of liver disease. These results suggest that portal diversion is an efficient and permanent treatment of intractable ascites in cirrhotic patients. Operative mortality and overall survival rates are similar to those observed after peritoneo-venous shunting. The peritoneo-venous shunt is preferable as the first-choice treatment of intractable ascites in cirrhotics because of the risk of encephalopathy. Portal diversion should be proposed for patients with previous variceal hemorrhage and for those in whom peritoneo-venous shunt has failed.

Entities:  

Mesh:

Year:  1983        PMID: 6873567

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  Intractable ascites in systemic mastocytosis treated by portal diversion.

Authors:  P Bonnet; C Smadja; A M Szekely; Y Delage; Y Calmus; R Poupon; D Franco
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.

Authors:  C Smadja; D Franco
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.